Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing

Oncology Reports

Volumn 10, Issue 1, 2003, Pages 175-179

  Andersson, Sonia ^a   Rylander, Eva ^b   Larson, Barbro ^a   Sigurdardóttir, Sunna ^c   Backlund, Ingrid ^c   Sällström, Jan ^c   Wilander, Erik ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenocarcinomas; Age; Cervix; DNA sequencing; HPV; PCR; Prevalence

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER STAGING; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADENOCARCINOMA; ADULT; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0141587059     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.1.175     Document Type: Article

References (36)

1. Parkin DM, Nguyen-Dinh X and Day NE: The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynecol 92: 150-157, 1985. (Pubitemid 15162720)
2. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841, 1999. (Pubitemid 29108856)
3. Paloma Vizcaino A, Moreno V, Bosch Xavier F, Munoz N, Barros-Dios XM and Parkin DM: International trends in the incidence of cervical cancer: 1. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 75: 536-545, 1998. (Pubitemid 28094098)
4. Zur Hausen H: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9-13, 1991.
5. Zur Hausen H: Papillomaviruses in human cancers. Proc Assoc Am Physicians 111: 581-587, 1999.
6. Brinton LA: Epidemiology of cervical cancer-overview. In: The Epidemiology of Human Papillomavirus and Cervical Cancer. Munoz N and Bosch FX (eds). IARC, Lyon, pp3-23, 1992.
7. Bosh FX, Manos MM, Munos N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurrman R and Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802, 1995.
8. Muñoz N: Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19: 1-5, 2000.
9. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999. (Pubitemid 29406813)
10. Iwasawa A, Nieminen P, Lehtinen M and Paavonen J: Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymeras chain reaction. Cancer 77: 2275-2279, 1996. (Pubitemid 26162420)
11. Tenti P, Romagnoli S, Silini E, Zappatore R, Spinillo A, GiuntaP, et al: Human Papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix. Anat Pathol 106: 52-56, 1996.
12. Zehbe I and Wilander E: Human papillomavirus infection and invasive cervical neoplasia: a study of prevalence and morphology. J Pathol 181: 270-275, 1997. (Pubitemid 27156838)
13. Hagmar B, Johansson B, Kalantari M, Petersson Z, Skyldberg B and Walaas L: The incidence of HPV in a Swedish series of invasive cervical carcinoma. Med Oncol Tumor Pharmacother 9: 113-117, 1992. (Pubitemid 23067286)
14. Sasieni P and Adams J: Changing rates of adenocarcinoma and adenosquamous carcinoma in cervix in England. Lancet 357: 1490-1493, 2001. (Pubitemid 32488859)
15. Herbert A, Singh N and Smith JAE: Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: a 12-year study in Southampton and South-west Hampshire. Cytopathology 12: 26-36, 2001. (Pubitemid 32205337)
16. Lungu O, Wright TC and Silverstein S: Typing of human papillomavirus by polymerase chain reaction amplification with LI consensus primer RFLP analysis. Mol Cell Probes 6: 145-152, 1992.
17. Saiki RK, Chang CA, Levenson CH, Warren TC, Boehm CD, Kazaian HH, et al: Diagnosis of sickle cell anemia and β-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N Engl J Med 319: 537-541, 1988.
18. Zehbe I, Evander M, Edlund K, Rylander E, Wadell G and Wilander E: Non-isotopic detection and typing of human papillomavirus (HPV) by use of polymerase chain reaction and single strand conformation polymorphism (PCR-SSCP). Diagn Mol Pathol 5: 206-213, 1996. (Pubitemid 26323982)
19. Zehbe I and Wilander E. Non-isotopic ELISA-based detection of human papillomavirus-amplified DNA. Mod Pathol 10: 188-191, 1997. (Pubitemid 27130456)
20. Alemi M, Andersson S, Sällström J and Wilander E: Rapid test for identification of human papillomavirus 16 E6 L83V variant. Diagn Mol Pathol 8: 97-100, 1999. (Pubitemid 29399039)
21. Breslow NE and Day NE: Statistical methods in cancer research. International Agency for Research on Cancer 1: 129-144, 1980.
22. Hording U, Teglbajaerg CS, Visfeldt J and Bock J: Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Gynecol Oncol 46: 313-316, 1992.
23. Milde-Langosch K, Schreiber C, Becker G, Löning T and Stegner HE: Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction. Hum Pathol 24: 590-594, 1993. (Pubitemid 23162225)
24. Duggan MA, McGregor SE, Benoit JL, Inoue M and Stuart GCE: The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis. Hum Pathol 26: 319-325, 1995.
25. Williams C, Ponten F, Moberg C, Soderkvist P, Uhlen M, Ponten J, Sitbon G and Lundeberg J: A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol 155: 1467-1471, 1999.
26. Park JS, Hwang ES, Park SN, Ahn HK, Um SJ, Kim CJ, Kim SJ and Namkoong SE: Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol 65: 121-129, 1997. (Pubitemid 27171562)
27. Yamakawa Y, Forslund O, Teshima H, Hasumi K, Kitagawa T and Hansson BG: Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol 53: 190-195, 1994. (Pubitemid 24177043)
28. Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, Richart RM and Isacson C: Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 157: 1055-1062, 2000.
29. Skyldberg BM, Murray E, Lambkin H, Kelehan P and Auer G: Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations. Mod Pathol 12: 675-682, 1999. (Pubitemid 29354880)
30. Stockton D, Cooper P and Lonsdale RN: Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia. J Med Screen 4: 40-43, 1997.
31. Tori T, Kurman RJ, Park JS, Kessis T and Shah KV: Probable non-papillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 10: 107-125, 1991.
32. Milde-Langosch K, Albrecht K, Joran S, Schlechte H, Giessing M and Loning T: Presence and persistence of HPV infection and p53 mutation in cancer of the cervix and vulva. Int J Cancer 63: 639-645, 1995.
33. Brinton LA, Huggins GR, Lehman HF, Mailin K, Savitz DA, Trapido E, et al: Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 38: 339-344, 1986. (Pubitemid 16022315)
34. Pater A, Bayatroup M and Pater MM: Onkogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestine from oral contraceptives. Am J Obstet Gynecol 162: 1099-1103, 1990. (Pubitemid 20155440)
35. Chilvers C, Mant D and Pire MC: Cervical adenocarcinoma and oral contraceptives. BMJ 295: 1446-1447, 1987. (Pubitemid 17159828)
36. Bergström R, Sparen P and Adami HO: Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 81: 159-166, 1999. (Pubitemid 29415507)